Medimune Pharmaceutical Private Limited
About Medimune Pharmaceutical Private Limited
Data last updated:
Medimune Pharmaceutical Private Limited is a private limited company based in Subhana, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2022PTC251908.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandip Roy and Akash Karmakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kumorpara Bus Stand Kpa Near Std Booth Srd Subhana North 24 Parganas, West Bengal, India – 743145.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.02 Lakh, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹31,040 (net margin 2.2%) and EBITDA of ₹41,960 (EBITDA margin 3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKumorpara Bus Stand Kpa Near Std Booth Srd Subhana North 24 Parganas, West Bengal, India – 743145
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medimune Pharmaceutical Private Limited
The main business activity of Medimune Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medimune Pharmaceutical Private Limited FY 2025 filings available
Medimune Pharmaceutical Private Limited reported revenue of ₹14.02 Lakh (up 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Medimune Pharmaceutical Private Limited
Revenue rose 35% in the latest year. EBITDA rose 876% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medimune Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹41,960 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31,040 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Medimune Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3% | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medimune Pharmaceutical are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medimune Pharmaceutical Private Limited
Medimune Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maauma Publication (OPC) Private Limited | ₹14.03 Lakh (FY 2019) | •••• | •••• | 244.0% | •••• | Medininagar, Jharkhand, India |
| Nerway Private Limited | ₹14.03 Lakh (FY 2021) | •••• | •••• | •••• | Kollam, Kerala, India | |
| Ranvakura Agriculture Producer Company Limited | ₹14.03 Lakh (FY 2025) | •••• | •••• | •••• | Deori, Madhya Pradesh, India | |
| Fam Technologies Private Limited | ₹14.03 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Vadodara, Gujarat, India |
| Kamsom Pharmaceuticals Private Limited | ₹14.03 Lakh (FY 2022) | •••• | •••• | -81.0% | •••• | Rohtak, Haryana, India |
| Medimune Pharmaceutical Private Limited this company | ₹14.02 Lakh (FY 2024) | •••• | •••• | 35.0% | •••• | Subhana, West Bengal, India |
| Trumount Pharmaceuticals Private Limited | ₹14.02 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | Baddi, Himachal Pradesh, India |
| Suresham Holding Private Limited | ₹14.02 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Kolkata, West Bengal, India |
| Votana Health Mart Private Limited | ₹14.02 Lakh (FY 2023) | •••• | •••• | 126.0% | •••• | Bathinda, Punjab, India |
| Vetmust Pharma Private Limited | ₹14.02 Lakh (FY 2022) | •••• | •••• | -13.0% | •••• | Faridabad, Haryana, India |
| Belki Petroleum Private Limited | ₹14.02 Lakh (FY 2019) | •••• | •••• | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Medimune Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medimune Pharmaceutical Private Limited
Medimune Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandip Roy | Director | 26 Feb 2022 | 4 Years 7 Months | Current |
| Akash Karmakar | Director | 26 Feb 2022 | 4 Years 7 Months | Current |
Charges & Borrowings of Medimune Pharmaceutical Private Limited
Medimune Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medimune Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Medimune Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medimune Pharmaceutical Private Limited
Medimune Pharmaceutical Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Priyanka Gupta ceased to be Director on 04 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Medimune Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medimune Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medimune Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medimune Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medimune Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medimune Pharmaceutical Private Limited
Medimune Pharmaceutical is an active private limited company based in Subhana, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2022 (4+ years old) and is registered under CIN U51909WB2022PTC251908.
Medimune Pharmaceutical reported revenue of ₹14.02 Lakh for FY 2024 (up 35% YoY).
Medimune Pharmaceutical has 2 current directors:
- Sandip Roy - Director
- Akash Karmakar - Director
Medimune Pharmaceutical reported a net profit of ₹31,040 (net margin 2.2%) and EBITDA of ₹41,960 (EBITDA margin 3%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Medimune Pharmaceutical is U51909WB2022PTC251908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medimune Pharmaceutical was incorporated on 26 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Medimune Pharmaceutical by revenue are Maauma Publication (OPC) Private Limited, Nerway Private Limited, Ranvakura Agriculture Producer Company Limited, Fam Technologies Private Limited, Kamsom Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Priyanka Gupta ceased to be Director on 04 Jul 2023. Akash Karmakar was appointed as Director on 26 Feb 2022. Sandip Roy was appointed as Director on 26 Feb 2022.
The registered office of Medimune Pharmaceutical is at Kumorpara Bus Stand Kpa Near Std Booth Srd Subhana North 24 Parganas, West Bengal, India – 743145.
Medimune Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Medimune Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.